Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Harvard Business School
Dow
Baxter
McKinsey

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Tasman Pharma Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for TASMAN PHARMA, and what generic alternatives to TASMAN PHARMA drugs are available?

TASMAN PHARMA has five approved drugs.

There is one US patent protecting TASMAN PHARMA drugs.

There are six patent family members on TASMAN PHARMA drugs in six countries and one supplementary protection certificate in one country.

Summary for Tasman Pharma
International Patents:6
US Patents:1
Tradenames:5
Ingredients:5
NDAs:5

Drugs and US Patents for Tasman Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tasman Pharma FLUOCINOLONE ACETONIDE fluocinolone acetonide OIL/DROPS;OTIC 213264-001 Feb 5, 2021 AT RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Tasman Pharma DROXIDOPA droxidopa CAPSULE;ORAL 213661-003 Feb 18, 2021 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Tasman Pharma CLOTRIMAZOLE clotrimazole SOLUTION;TOPICAL 212281-001 Jul 25, 2019 AT RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Tasman Pharma DROXIDOPA droxidopa CAPSULE;ORAL 213661-002 Feb 18, 2021 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Tasman Pharma VERSACLOZ clozapine SUSPENSION;ORAL 203479-001 Feb 6, 2013 RX Yes Yes 8,057,811 ⤷  Sign up for a Free Trial Y ⤷  Sign up for a Free Trial
Tasman Pharma DROXIDOPA droxidopa CAPSULE;ORAL 213661-001 Feb 18, 2021 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Tasman Pharma KETOCONAZOLE ketoconazole CREAM;TOPICAL 215185-001 Nov 17, 2021 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for Tasman Pharma Drugs

Country Patent Number Estimated Expiration
European Patent Office 1646393 ⤷  Sign up for a Free Trial
New Zealand 527142 ⤷  Sign up for a Free Trial
World Intellectual Property Organization (WIPO) 2005007168 ⤷  Sign up for a Free Trial
Spain 2436213 ⤷  Sign up for a Free Trial
Australia 2004257556 ⤷  Sign up for a Free Trial
Canada 2532648 ⤷  Sign up for a Free Trial
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for Tasman Pharma Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2233112 132014902285293 Italy ⤷  Sign up for a Free Trial PRODUCT NAME: FLUOCINOLONE ACETONIDE(ILUVIEN); AUTHORISATION NUMBER(S) AND DATE(S): 042616019, 20140530;PL27813/0001, 20120504
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Moodys
Express Scripts
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.